Viewing Study NCT03674866


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-02-03 @ 7:23 AM
Study NCT ID: NCT03674866
Status: COMPLETED
Last Update Posted: 2019-12-06
First Post: 2018-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module